Skip to content

The Bowdoin Group’s Dave Melville to Speak on Goodwin Proctor’s Jumpstart Bio Breakfast Series Panel

Posted by Lauren Kendall on February 13, 2019
BOSTON, Mass., February 13, 2019 – The Bowdoin Group is pleased partner with Goodwin’s Jumpstart Bio breakfast series which gathers leaders in the Boston biotech and pharmaceutical community to discuss the intersection of science, business, and the law. This series equips drug development and commercialization professionals to anticipate, prepare for, and respond to issues on the horizon for the industry.

Join us for “Hiring and Pay Equity Laws: Are You Doing It Right? Maybe not.”

The hiring and talent acquisition landscape has changed dramatically over the last few years as companies battle over the best talent in a low-supply market. Further complicating matters, the MA Legislature passed a significant new law impacting compensation. Most companies are aware of the Massachusetts Equal Pay Act (MEPA) and many have taken advantage of the self-evaluation process but initial compliance efforts are not enough. It is abundantly important to establish the right practices going forward to avoid procedural missteps that may put your company and its reputation at risk.

Jennifer Fay, Partner at Goodwin, and Dave Melville, CEO & Founder of The Bowdoin Group, will discuss the actualities and the practical applications in navigating the new hiring landscape in today’s BioPharma environment on Thursday, March 7th, 2019. You can RSVP for this fireside chat using this link.

Please reach out to with any questions.